• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意想不到的大 B 环抗雄激素的结合取向及其对未来药物靶点的影响。

Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.

机构信息

Department of Pharmaceutical Sciences, The University of Tennessee, Memphis, TN 38163, USA.

出版信息

J Med Chem. 2011 Jun 9;54(11):3973-6. doi: 10.1021/jm2000097. Epub 2011 May 16.

DOI:10.1021/jm2000097
PMID:21506597
Abstract

Several new androgen receptor antagonists were synthesized and found to have varying activities across typically anti-androgen resistant mutants (Thr877 → Ala and Trp741 → Leu) and markedly improved potency over previously reported pan-antagonists. X-ray crystallography of a new anti-androgen in an androgen receptor mutant (Thr877 → Ala) shows that the receptor can accommodate the added bulk presented by phenyl to naphthyl substitution, casting doubt on previous reports of predicted binding orientation and the causes of antagonism in bulky-B-ring antagonists.

摘要

几种新的雄激素受体拮抗剂被合成出来,并发现它们对通常抗雄激素耐药的突变体(Thr877→Ala 和 Trp741→Leu)具有不同的活性,并且比以前报道的泛拮抗剂具有显著提高的效力。一种新的雄激素拮抗剂在雄激素受体突变体(Thr877→Ala)中的 X 射线晶体学表明,受体可以容纳苯环到萘环取代所带来的额外体积,这对以前关于预测结合方向的报告以及在大体积 B 环拮抗剂中产生拮抗作用的原因提出了质疑。

相似文献

1
Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.意想不到的大 B 环抗雄激素的结合取向及其对未来药物靶点的影响。
J Med Chem. 2011 Jun 9;54(11):3973-6. doi: 10.1021/jm2000097. Epub 2011 May 16.
2
Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)benzonitrile.含硼烷的雄激素受体拮抗剂 3-(12-羟甲基-1,12-二碳硼烷-1-基)苯甲腈的晶体结构、对接研究及构效关系。
Bioorg Med Chem. 2011 Jun 1;19(11):3540-8. doi: 10.1016/j.bmc.2011.04.017. Epub 2011 Apr 20.
3
Subtle structural changes in tetrahydroquinolines, a new class of nonsteroidal selective androgen receptor modulators, induce different functions.四氢喹啉结构的细微变化会导致新型非甾体选择性雄激素受体调节剂产生不同的功能。
J Chem Inf Model. 2012 Aug 27;52(8):2257-64. doi: 10.1021/ci300219g. Epub 2012 Aug 2.
4
Androgen receptor antagonists: a patent review (2008-2011).雄激素受体拮抗剂:专利研究综述(2008-2011)。
Expert Opin Ther Pat. 2012 May;22(5):541-65. doi: 10.1517/13543776.2012.682571.
5
Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen-independent prostate cancer.雄激素受体轴的分子建模:雄激素受体干预雄激素非依赖性前列腺癌的合理依据。
BJU Int. 2005 Dec;96 Suppl 2:2-9. doi: 10.1111/j.1464-410X.2005.05940.x.
6
Androgen receptor as a therapeutic target.雄激素受体作为治疗靶点。
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1277-84. doi: 10.1016/j.addr.2010.08.002. Epub 2010 Aug 12.
7
Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists.设计苯并咪唑和吲哚酮类化合物作为新型雄激素受体拮抗剂。
Bioorg Med Chem Lett. 2012 Apr 1;22(7):2572-8. doi: 10.1016/j.bmcl.2012.01.116. Epub 2012 Feb 7.
8
Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists.设计、合成及 4-苯基吡咯衍生物作为新型雄激素受体拮抗剂的生物评价。
Bioorg Med Chem. 2012 Jan 1;20(1):422-34. doi: 10.1016/j.bmc.2011.10.067. Epub 2011 Oct 28.
9
Discovery of diarylhydantoins as new selective androgen receptor modulators.发现二芳基乙内酰脲类化合物作为新型选择性雄激素受体调节剂。
J Med Chem. 2012 Oct 11;55(19):8225-35. doi: 10.1021/jm300249m. Epub 2012 Sep 25.
10
Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.作为雄激素受体拮抗剂的泛酰巯基乙胺用于局部皮脂抑制。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5230-3. doi: 10.1016/j.bmcl.2011.07.048. Epub 2011 Jul 23.

引用本文的文献

1
A Computational and In Vitro Appraisal of Ostarine to Target Androgen Receptor in Glioma C6 Cells.奥司他丁对胶质瘤C6细胞中雄激素受体作用靶点的计算分析及体外评估
Cell Biochem Biophys. 2025 Jun 13. doi: 10.1007/s12013-025-01797-0.
2
A partially open conformation of an androgen receptor ligand-binding domain with drug-resistance mutations.雄激素受体配体结合域的部分开放构象与耐药突变。
Acta Crystallogr F Struct Biol Commun. 2023 Apr 1;79(Pt 4):95-104. doi: 10.1107/S2053230X23002224. Epub 2023 Mar 30.
3
Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies.
含腈类药物:作用靶点、作用机制及其构效关系研究
RSC Med Chem. 2021 Aug 10;12(10):1650-1671. doi: 10.1039/d1md00131k. eCollection 2021 Oct 20.
4
Binding of Androgen- and Estrogen-Like Flavonoids to Their Cognate (Non)Nuclear Receptors: A Comparison by Computational Prediction.雄激素和雌激素样类黄酮与其同源(非)核受体的结合:通过计算预测进行比较。
Molecules. 2021 Mar 14;26(6):1613. doi: 10.3390/molecules26061613.
5
Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer.比卡鲁胺类似物的合成及生物评价及其在前列腺癌治疗中的应用潜力。
Molecules. 2020 Dec 24;26(1):56. doi: 10.3390/molecules26010056.
6
Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.雄激素受体的内分泌干扰:运用分子动力学和对接提高虚拟筛选和毒性预测的能力。
Int J Mol Sci. 2018 Jun 15;19(6):1784. doi: 10.3390/ijms19061784.
7
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.雄激素诱导前列腺癌和乳腺癌细胞凋亡的统一生物学。
Endocr Relat Cancer. 2018 Feb;25(2):R83-R113. doi: 10.1530/ERC-17-0416. Epub 2017 Nov 21.
8
Predictive Structure-Based Toxicology Approaches To Assess the Androgenic Potential of Chemicals.基于预测结构的毒理学方法评估化学品的雄激素潜力
J Chem Inf Model. 2017 Nov 27;57(11):2874-2884. doi: 10.1021/acs.jcim.7b00420. Epub 2017 Oct 26.
9
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies.调整不对称环三氮二磺酰胺(CADA)内质网(ER)易位抑制剂中的侧臂电子结构以提高其对人分化簇4(CD4)受体的下调效力。
J Med Chem. 2016 Mar 24;59(6):2633-47. doi: 10.1021/acs.jmedchem.5b01832. Epub 2016 Mar 14.
10
Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance.靶向激素结合口袋以规避基于突变的抗性的抗雄激素设计进展。
Front Pharmacol. 2015 Mar 24;6:57. doi: 10.3389/fphar.2015.00057. eCollection 2015.